Brief: Hybrigenics recruits first patient in the clinical study of Inecalcitol
13/09/2016 17:15
Sept 13 (Reuters) - Hybrigenics SA ALHYG.PA :
* Recruits the first patient in the clinical study of
Inecalcitol in acute myeloid leukemia
Source text for Eikon: http://bit.ly/2cpnU4p
Further company coverage: ALHYG.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million